Thomas Bartlett

As the result of his professional background working at companies such as Apple, Dell, and with a Life Science Consulting Firm, Thomas Bartlett found himself needing to make a difference in the world of myasthenia gravis (MG). He began consulting for pharmaceutical companies in the MG space. Now, he speaks about applied technologies to improve quality of life through real-time data acquisition and analysis. This includes leveraging wearables and textiles to measure data to understand and prevent catastrophic outcomes with MG.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.